Board of Directors

Dr. Jörg Kneubühler
Chairman of the Board of Directors

• Elected since 2017
• Born 1960, Swiss citizen
• Dr. rer. pol., University of Bern
• Held various positions in finance at the Swatch Group before joining Galenica
• Joined the former Galenica Group in 2002 as Head of Finance and Administration at Vifor Pharma; Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and member of the Corporate Executive Committee from 2009; CFO from 2012 to 2016; and CEO Galenica Santé from 2014 to Q1 2017

Daniela Bosshardt-Hengartner

• Elected since 2017
• Born 1972, Swiss citizen
• Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich
• Financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004)
• Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
• Member of the Board of Directors of RepRisk AG (Zurich), Vifor Pharma Ltd. (Zürich) and investiere.ch (Baar)

Prof. Dr. Michel Burnier

• Elected since 2017
• Born 1953, Swiss citizen
• Swiss-registered Doctor of Internal Medicine and Nephrology
• University Lecturer, University of Lausanne
• Member of the following organisations: Swiss Society of Nephrology (former President), European Society of Hypertension (council member and Treasurer) and Swiss Society of Hypertension (former President)
• Formerly a member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002-2010)
• Member of the Board of Directors of Speedel Holding Ltd. (Basel) from 2007 to 2009
• Member of the Board of Directors of Vifor Pharma Ltd. (Zurich)

Fritz Hirsbrunner

• Elected since 2017
• Born 1949, Swiss citizen
• Lic. oec., HEC University of Lausanne / Senior Executive Program, IMD, Lausanne
• 1972–1977 Controller at Ciba-Geigy
• Joined the former Galenica Group in 1977 as Assistant to the Corporate Executive Committee; member of the Corporate Executive Committee from 1992 to 2011; Deputy CEO and CFO; Head Investor Relations until 2014 Member of the Board of Trustees of IST Investmentstiftung für Personalvorsorge (Zurich)
• Member of the Board of Directors of Berlac AG (Sissach), IVF Hartmann Holding AG (Neuhausen), VenCap 6 Ltd. (Jersey) and Vifor Pharma Ltd. (Zurich)

Dr. Philippe Nussbaumer

• Elected since 2017
• Born 1969, Swiss citizen
• FPH Pharmacist, Federal Diploma / PhD in Pharmaceutical Sciences, University of Geneva / dipl. oec. HEC, University of Lausanne
• Federal Ski Instructor Diploma and Federal Expert J+S; since 2004, Vice-President of the Swiss Snowsports School of Neuchâtel / Les Bugnenets
• Owner and president of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds
• Since 2007, founder and administrator of Ecopharma pharmacy brand
• Since 2014, owner and president of the Medi-Centre Ltd. medical centre in La Chaux-de-Fonds
• Since 2012, Member of the Board of Directors of Veripharm Ltd.

Dr. Andreas Walde

• Elected since 2017
• Born 1962, Swiss citizen
• Attorney-at-law and doctorate in law, University of Basel
• Various legal and management positions in the chemical and pharmaceutical industry for more than 25 years: 1988-1996 at Roche, 1998-2010 at Clariant and 2012-2013 at Petroplus, in the latter two notably as group general counsel; General Secretary of Vifor Pharma Ltd. (Zurich), former Galenica Group, since 2013
• Former positions include memberships on the boards of several private (non-Swiss) public listed companies as well as on the board of the Society of Swiss Enterprises in Germany
• Member of the Board of SwissHoldings, the Federation of Industrial and Service Groups in Switzerland